Compare APLE & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APLE | ALVO |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 1.6B |
| IPO Year | 2015 | N/A |
| Metric | APLE | ALVO |
|---|---|---|
| Price | $12.20 | $4.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $14.17 | $9.25 |
| AVG Volume (30 Days) | ★ 2.9M | 606.7K |
| Earning Date | 11-03-2025 | 11-12-2025 |
| Dividend Yield | ★ 8.30% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.74 | 0.24 |
| Revenue | ★ $1,418,986,000.00 | $573,350,000.00 |
| Revenue This Year | $0.53 | $20.97 |
| Revenue Next Year | $2.22 | $43.04 |
| P/E Ratio | ★ $16.55 | $20.40 |
| Revenue Growth | 0.57 | ★ 45.55 |
| 52 Week Low | $10.44 | $4.32 |
| 52 Week High | $16.02 | $13.70 |
| Indicator | APLE | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 58.78 | 40.53 |
| Support Level | $11.46 | $4.67 |
| Resistance Level | $12.42 | $5.85 |
| Average True Range (ATR) | 0.22 | 0.36 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 74.61 | 40.85 |
Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.